As the battle for the weight-loss…
As the battle for the weight-loss market expands to oral [...]
As the battle for the weight-loss market expands to oral [...]
A year after revealing his “Liberation Day” trade policy initiatives, [...]
Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 [...]
Alto Neurosciences is halting work on its schizophrenia prospect after [...]
After the FDA placed two of its next-gen HIV drugs [...]
Stipple Bio is connecting the dots toward multiple early-stage clinical [...]
After emerging from stealth last month with $175 million in [...]
Oric Pharmaceuticals has picked the phase 3 dose for its [...]
Have we passed the peak of biotech layoffs? It’s too [...]
Iran’s foreign minister, Abbas Araghchi, said on Tuesday that Israel [...]